JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Sumit Bose as Independent Director of the company w.e.f. August 31, 2025.
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has re-appointed Mr. Sumit Bose (DIN: 03340616) as an Independent Director for a second term of 5 years, effective August 31, 2025. Mr. Bose is a retired IAS officer who previously served as Union Finance Secretary, Secretary (Expenditure), Secretary (Disinvestment), and Secretary in the Thirteenth Finance Commission. He holds an MSc in Social Policy and Planning from the London School of Economics and an MA in History from St. Stephen's College, Delhi. He currently serves on the boards of HDFC Life Insurance, JM Financial, and several other listed and non-profit organisations. The filing confirms he is not debarred by SEBI and has no family relationship with any other director on the board.
This is a routine board re-appointment with no change in control or strategy. Retaining a director with Mr. Bose's strong public-sector and financial governance experience is mildly positive for board quality and minority shareholder interests, but unlikely to move the stock price.